Louisiana legislation · 2026 Regular Session
Louisiana SB236: HEALTH CARE: Provides relative to kidney disease. (8/1/26) (EN NO IMPACT See Note)
Status: Signed into law, May 29, 2026
What the bill says
An act To enact R.S. 46:450.5.1, relative to kidney disease; to provide for legislative intent; to provide for requirements for the Louisiana Department of Health; to provide for annual reviews; to provide for reporting; and to provide for related matters.
From the introduced text:
AN ACT To enact R.S. 46:450.5.1, relative to kidney disease; to provide for legislative intent; to provide for requirements for the Louisiana Department of Health; to provide for annual reviews; to provide for reporting; and to provide for related matters. Be it enacted by the Legislature of Louisiana: Section 1. R.S. 46:450.5.1 is hereby enacted to read as follows: §450.5.1. Chronic and rare kidney diseases; coverage; annual review A. The legislature hereby finds that: (1) More than thirty-five million Americans currently suffer from kidney disease and millions more may not be aware that they are at risk for developing kidney disease in the future. (2) There is a new era emerging of clinical innovation in kidney disease treatment, with the first-ever treatments approved by the United States Food and Drug Administration to slow the decline of kidney function in patients with chronic kidney disease and rare kidney diseases. (3) Although the main causes of kidney disease are diabetes and high blood pressure, kidney disease also has genetic and hereditary causes, including Page 1 of Coding: Words which are struck through are deletions from existing law; words in boldface type and underscored are additions. SLS 26RS-499 ORIGINAL SB NO. rare diseases that cause glomerulonephritis. (4) According to the Centers for Disease Control and Prevention, as many as nine out of ten …
Sponsors
- Owen, Robert (R, 1) · primary sponsor
- Chassion, Tehmi (D, 44)
Latest actions
- : Effective date 8/1/2026.
- : Signed by the Governor. Becomes Act No. 478.
- : Signed by the Speaker of the House.
- : Sent to the Governor by the Secretary of the Senate.
- : Enrolled. Signed by the President of the Senate.
- : Amendments proposed by the House read and concurred in by a vote of 30 yeas and 0 nays.
- : Received from the House with amendments.
- : Read third time by title, roll called on final passage, yeas 88, nays 7. The bill, having received two-thirds vote of the elected members, was finally passed, ordered to the Senate.
- : Scheduled for floor debate on 05/19/2026.
- : Read by title, amended, passed to 3rd reading.
Votes
- Senate Vote on SB 236, CONCUR (#1056) (May 20, 2026): 30 yea, 0 nay, passed
- House Vote on SB 236, FINAL PASSAGE (#1362) (May 19, 2026): 88 yea, 7 nay, passed
- Senate Vote on SB 236, FINAL PASSAGE (#183) (March 30, 2026): 36 yea, 0 nay, passed
Common questions
- What is SB236?
- SB236 is a bill in the Louisiana Legislature (2026 Regular Session): HEALTH CARE: Provides relative to kidney disease. (8/1/26) (EN NO IMPACT See Note).
- What does SB236 do?
- In its own words: An act To enact R.S. 46:450.5.1, relative to kidney disease; to provide for legislative intent; to provide for requirements for the Louisiana Department of Health; to provide for annual reviews; to provide for reporting; and to provide for related matters.
- What is the status of SB236?
- Signed into law as of May 29, 2026. Latest action: Effective date 8/1/2026. (May 29, 2026).
- Who sponsored SB236?
- Owen, Robert (R, 1), with 1 co-sponsor.
- Where is the official record for SB236?
- On the Louisiana Legislature website: https://legis.la.gov/legis/BillInfo.aspx?s=26RS&b=SB236
Source: official Louisiana record. Tracked by Delilah, AI for legislation across all 50 states and Congress.